Annual Total Liabilities
$28.53 M
-$1.75 M-5.78%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual total liabilities is $28.53 million, with the most recent change of -$1.75 million (-5.78%) on December 31, 2023.
- During the last 3 years, ALDX annual total liabilities has risen by +$4.69 million (+19.66%).
- ALDX annual total liabilities is now -5.78% below its all-time high of $30.28 million, reached on December 31, 2022.
Performance
ALDX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$32.22 M
+$4.49 M+16.19%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly total liabilities is $32.22 million, with the most recent change of +$4.49 million (+16.19%) on September 30, 2024.
- Over the past year, ALDX quarterly total liabilities has increased by +$7.95 million (+32.75%).
- ALDX quarterly total liabilities is now at all-time high.
Performance
ALDX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ALDX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.8% | +32.8% |
| 3 y3 years | +19.7% | +17.0% |
| 5 y5 years | +236.7% | +21.3% |
ALDX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +4.1% | at high | +32.8% |
| 5 y | 5-year | -5.8% | +19.7% | at high | +71.1% |
| alltime | all time | -5.8% | +1039.9% | at high | +1519.0% |
Aldeyra Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.22 M(+16.2%) |
| Jun 2024 | - | $27.73 M(-0.5%) |
| Mar 2024 | - | $27.88 M(-2.3%) |
| Dec 2023 | $28.53 M(-5.8%) | $28.53 M(+17.5%) |
| Sep 2023 | - | $24.27 M(-5.7%) |
| Jun 2023 | - | $25.73 M(-16.9%) |
| Mar 2023 | - | $30.98 M(+2.3%) |
| Dec 2022 | $30.28 M(+10.5%) | $30.28 M(+10.1%) |
| Sep 2022 | - | $27.50 M(+1.9%) |
| Jun 2022 | - | $26.99 M(-15.7%) |
| Mar 2022 | - | $32.00 M(+16.8%) |
| Dec 2021 | $27.40 M(+14.9%) | $27.40 M(-0.5%) |
| Sep 2021 | - | $27.55 M(+21.1%) |
| Jun 2021 | - | $22.75 M(+7.1%) |
| Mar 2021 | - | $21.23 M(-11.0%) |
| Dec 2020 | $23.84 M(-13.1%) | $23.84 M(+24.5%) |
| Sep 2020 | - | $19.15 M(+1.7%) |
| Jun 2020 | - | $18.84 M(-3.7%) |
| Mar 2020 | - | $19.56 M(-28.7%) |
| Dec 2019 | $27.44 M(+223.8%) | $27.44 M(+3.3%) |
| Sep 2019 | - | $26.56 M(+308.3%) |
| Jun 2019 | - | $6.51 M(-32.6%) |
| Mar 2019 | - | $9.65 M(+13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $8.47 M(+85.3%) | $8.47 M(-0.7%) |
| Sep 2018 | - | $8.54 M(+35.4%) |
| Jun 2018 | - | $6.31 M(+32.1%) |
| Mar 2018 | - | $4.77 M(+4.4%) |
| Dec 2017 | $4.57 M(+29.3%) | $4.57 M(+37.6%) |
| Sep 2017 | - | $3.32 M(+6.3%) |
| Jun 2017 | - | $3.13 M(-11.6%) |
| Mar 2017 | - | $3.54 M(-0.0%) |
| Dec 2016 | $3.54 M(+6.4%) | $3.54 M(+0.5%) |
| Sep 2016 | - | $3.52 M(+4.6%) |
| Jun 2016 | - | $3.37 M(+15.7%) |
| Mar 2016 | - | $2.91 M(-12.5%) |
| Dec 2015 | $3.33 M(+32.9%) | $3.33 M(+25.3%) |
| Sep 2015 | - | $2.65 M(+12.8%) |
| Jun 2015 | - | $2.35 M(+11.8%) |
| Mar 2015 | - | $2.10 M(-15.9%) |
| Dec 2014 | $2.50 M(-55.7%) | $2.50 M(+19.9%) |
| Sep 2014 | - | $2.09 M(+4.9%) |
| Jun 2014 | - | $1.99 M(-50.6%) |
| Mar 2014 | - | $4.03 M(-28.7%) |
| Dec 2013 | $5.65 M(-79.2%) | $5.65 M(-61.3%) |
| Sep 2013 | - | $14.58 M(-46.3%) |
| Dec 2012 | $27.13 M(+946.1%) | $27.13 M |
| Dec 2011 | $2.59 M | - |
FAQ
- What is Aldeyra Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual total liabilities year-on-year change?
- What is Aldeyra Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly total liabilities year-on-year change?
What is Aldeyra Therapeutics annual total liabilities?
The current annual total liabilities of ALDX is $28.53 M
What is the all time high annual total liabilities for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual total liabilities is $30.28 M
What is Aldeyra Therapeutics annual total liabilities year-on-year change?
Over the past year, ALDX annual total liabilities has changed by -$1.75 M (-5.78%)
What is Aldeyra Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ALDX is $32.22 M
What is the all time high quarterly total liabilities for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly total liabilities is $32.22 M
What is Aldeyra Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ALDX quarterly total liabilities has changed by +$7.95 M (+32.75%)